124
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Effects of once-daily extended release quetiapine fumarate on patient-reported outcomes in patients with generalized anxiety disorder

, &
Pages 301-311 | Published online: 11 Jul 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Benchalak Maneeton, Suwannee Putthisri, Narong Maneeton, Pakapan Woottiluk, Sirijit Suttajit, Chawanun Charnsil & Manit Srisurapanont. (2017) Quetiapine monotherapy versus placebo in the treatment of children and adolescents with bipolar depression: a systematic review and meta-analysis. Neuropsychiatric Disease and Treatment 13, pages 1023-1032.
Read now
Narong Maneeton, Benchalak Maneeton, Pakapan Woottiluk, Surinporn Likhitsathian, Sirijit Suttajit, Vudhichai Boonyanaruthee & Manit Srisurapanont. (2016) Quetiapine monotherapy in acute treatment of generalized anxiety disorder: a systematic review and meta-analysis of randomized controlled trials. Drug Design, Development and Therapy 10, pages 259-276.
Read now
Massimiliano Buoli, Massimo Carlo Mauri & Alfredo Carlo Altamura. (2014) Pharmacokinetic evaluation of agomelatine for the treatment of generalised anxiety disorder. Expert Opinion on Drug Metabolism & Toxicology 10:6, pages 885-892.
Read now

Articles from other publishers (9)

Radomir Juza, Kamil Musilek, Eva Mezeiova, Ondrej Soukup & Jan Korabecny. (2022) Recent advances in dopamine D 2 receptor ligands in the treatment of neuropsychiatric disorders . Medicinal Research Reviews 43:1, pages 55-211.
Crossref
Baptiste Pignon, Chloé Tezenas du Montcel, Louise Carton & Antoine Pelissolo. (2017) The Place of Antipsychotics in the Therapy of Anxiety Disorders and Obsessive-Compulsive Disorders. Current Psychiatry Reports 19:12.
Crossref
Wade Thompson, Teo A.W. Quay, Carlos Rojas-Fernandez, Barbara Farrell & Lise M. Bjerre. (2016) Atypical antipsychotics for insomnia: a systematic review. Sleep Medicine 22, pages 13-17.
Crossref
Joseph Calabrese, Krithika Rajagopalan, Daisy Ng-Mak, Elizabeth D. Bacci, Kathy Wyrwich, Andrei Pikalov & Antony Loebel. (2016) Effect of lurasidone on meaningful change in health-related quality of life in patients with bipolar depression. International Clinical Psychopharmacology 31:3, pages 147-154.
Crossref
Giampaolo Perna, Alessandra Alciati, Alice Riva, Wilma Micieli & Daniela Caldirola. (2016) Long-Term Pharmacological Treatments of Anxiety Disorders: An Updated Systematic Review. Current Psychiatry Reports 18:3.
Crossref
MÁRCIO G. SOEIRO-DE-SOUZA, VASCO VIDEIRA DIAS, GIOVANNI MISSIO, VICENT BALANZÁ-MARTINEZ, LEANDRO VALIENGO, ANDRÉ F. CARVALHO & RICARDO ALBERTO MORENO. (2015) Role of quetiapine beyond its clinical efficacy in bipolar disorder: From neuroprotection to the treatment of psychiatric disorders (Review). Experimental and Therapeutic Medicine 9:3, pages 643-652.
Crossref
Hilary Wilson, Sally Mannix, Hafiz Oko-osi & Dennis A. Revicki. (2014) The Impact of Medication on Health-Related Quality of Life in Patients with Generalized Anxiety Disorder. CNS Drugs 29:1, pages 29-40.
Crossref
Robert E. Brutcher & Michael A. Nader. (2014) Effects of quetiapine treatment on cocaine self-administration and behavioral indices of sleep in adult rhesus monkeys. Psychopharmacology 232:2, pages 411-420.
Crossref
Jürgen Hoyer & Jens Plag. (2013) Generalisierte Angststörung. PSYCH up2date 7:02, pages 89-104.
Crossref